Literature DB >> 20117671

Hypoglycemia during acute illness in children with classic congenital adrenal hyperplasia.

Margaret F Keil1, Charlotte Bosmans, Carol Van Ryzin, Deborah P Merke.   

Abstract

Congenital adrenal hyperplasia (CAH) describes a group of genetic, autosomal recessive conditions, where there is a block in cortisol biosynthesis. Approximately 95 percent of cases are due to 21-hydroxylase deficiency, which is discussed in this article. Patients with the severe or classic form of CAH have epinephrine deficiency in addition to cortisol deficiency. Both epinephrine and cortisol are important counterregulatory hormones and help prevent hypoglycemia during physical stress. This is the first prospective study to evaluate the incidence of hypoglycemia during acute illness in children with classic CAH. Our objective was to examine blood glucose levels and symptoms of these children during the physical stressor of a typical acute illness managed at home. Twenty patients, ages 3 to 10 years with classic CAH participated. Parents were instructed regarding management of illnesses, home blood glucose monitoring and questionnaire completion. Over 29 months, 20 patients completed questionnaires and 6 patients performed home blood glucose monitoring. A blood glucose of <60 mg/dL was documented in 3 out of 8 monitored acute illness episodes, and in 2 out of 6 of monitored children. The acute illness episodes with documented blood glucose <60 mg/dL were not associated with vomiting. Our data suggest that children with classic CAH may experience lowering of blood glucose during illnesses, and patient education regarding the management of common childhood illness should include glucose supplementation. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20117671      PMCID: PMC2819226          DOI: 10.1016/j.pedn.2008.06.003

Source DB:  PubMed          Journal:  J Pediatr Nurs        ISSN: 0882-5963            Impact factor:   2.145


  16 in total

1.  Hypoglycaemia in congenital adrenal hyperplasia.

Authors:  J Mackinnon; D B Grant
Journal:  Arch Dis Child       Date:  1977-07       Impact factor: 3.791

2.  Response to treatment of congenital adrenal hyperplasia in infancy.

Authors:  M C Young; I A Hughes
Journal:  Arch Dis Child       Date:  1990-04       Impact factor: 3.791

3.  Growth and final height in classical and nonclassical 21-hydroxylase deficiency.

Authors:  M I New; J M Gertner; P W Speiser; P del Balzo
Journal:  Acta Paediatr Jpn       Date:  1988

4.  Acute dehydrating diarrhea. Clinical profile in neonates & young infants.

Authors:  T S Daral; H P Singh; H P Sachdev; M Mohan; M Mathur; S K Bhargava
Journal:  Indian Pediatr       Date:  1985-05       Impact factor: 1.411

5.  Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog.

Authors:  A T Soliman; M AlLamki; I AlSalmi; M Asfour
Journal:  Metabolism       Date:  1997-05       Impact factor: 8.694

6.  Plasma catecholamines and the counterregulatory responses to hypoglycemia in infants: a critical role for epinephrine and cortisol.

Authors:  Lesley Jackson; Fiona L R Williams; Ann Burchell; Michael W H Coughtrie; Robert Hume
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

7.  Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens.

Authors:  R Rasat; E A Espiner; G D Abbott
Journal:  N Z Med J       Date:  1995-08-11

8.  Blood sugar in infantile gastro-enteritis.

Authors:  R Glyn-Jones
Journal:  S Afr Med J       Date:  1975-08-23

9.  Hypoglycemia during diarrhea in childhood. Prevalence, pathophysiology, and outcome.

Authors:  M L Bennish; A K Azad; O Rahman; R E Phillips
Journal:  N Engl J Med       Date:  1990-05-10       Impact factor: 91.245

10.  Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency.

Authors:  M D Donaldson; P H Thomas; J G Love; G D Murray; A W McNinch; D C Savage
Journal:  Arch Dis Child       Date:  1994-03       Impact factor: 3.791

View more
  6 in total

Review 1.  Management of Childhood Congenital Adrenal Hyperplasia-An Integrative Review of the Literature.

Authors:  Louise Fleming; Marcia Van Riper; Kathleen Knafl
Journal:  J Pediatr Health Care       Date:  2017-04-13       Impact factor: 1.812

2.  Low Adrenomedullary Function Predicts Acute Illness in Infants With Classical Congenital Adrenal Hyperplasia.

Authors:  Jonathan Weber; Veeraya K Tanawattanacharoen; Amy Seagroves; Mark C Liang; Christina M Koppin; Heather M Ross; Tania A S S Bachega; Mitchell E Geffner; Monica Serrano-Gonzalez; Gagandeep Bhullar; Mimi S Kim
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 6.134

3.  Devastating salt-wasting crisis in a four-month-old male child with congenital adrenal hyperplasia, highlighting the essence of neonatal screening.

Authors:  Nagaspurthy Anugu Reddy; Sucheta Sharma; Mainak Das; Ashutosh Kapoor; Upasana Maskey
Journal:  Clin Case Rep       Date:  2022-07-11

4.  Decreased adrenomedullary function in infants with classical congenital adrenal hyperplasia.

Authors:  Mimi S Kim; Anna Ryabets-Lienhard; Bhavna Bali; Christianne J Lane; Ashley H Park; Sandra Hall; Mitchell E Geffner
Journal:  J Clin Endocrinol Metab       Date:  2014-05-30       Impact factor: 5.958

5.  Longitudinal Assessment of Illnesses, Stress Dosing, and Illness Sequelae in Patients With Congenital Adrenal Hyperplasia.

Authors:  Diala El-Maouche; Courtney J Hargreaves; Ninet Sinaii; Ashwini Mallappa; Padmasree Veeraraghavan; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2018-06-01       Impact factor: 5.958

6.  Improved medical-alert ID ownership and utilization in youth with congenital adrenal hyperplasia following a parent educational intervention.

Authors:  Alaina P Vidmar; Jonathan F Weber; Roshanak Monzavi; Christina M Koppin; Mimi S Kim
Journal:  J Pediatr Endocrinol Metab       Date:  2018-01-26       Impact factor: 1.520

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.